Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could probiotic cream soothe Children's dry skin?

NCT ID NCT07713303

Disease control Sponsor: BioGaia AB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a cream containing probiotics can safely improve dry skin in children from birth to 7 years old. About 40 children will apply the cream twice daily for 4 weeks at home. Doctors will measure changes in skin dryness using a standard score and parent reports. The goal is to see if this non-medicated cream helps manage dry skin without side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a probiotic-containing cream
What this could lead to
If it works, this could offer a gentle, non-medicated option for managing dry skin in young children.
What could go wrong
This is a small, early-stage trial with no control group, so results may not prove the cream is better than a placebo or other treatments.
Why investors are watching

BioGaia is testing a probiotic cream in 40 children with dry skin, measuring changes in a standard dryness score over four weeks. For a small company, this readout offers an early signal on whether its probiotic approach can work outside the gut, which could shape its pipeline and market story.

If it works: A positive result could support BioGaia's entry into topical skin care and give it a product candidate with real-world home-use data. That could broaden its business beyond oral probiotics and attract partnership interest.

If it fails: The trial is small and open-label, so even a positive result may not prove much. If the cream fails to improve dryness or shows safety problems, BioGaia would likely abandon this product line, and the stock could lose value.

AI-written from the trial record. Speculative, and not investment advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 months to 7 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Newborn - 7 years. 2. ODS ≥ 2 in the target area. 3. Parent/guardian able to comply with weekly diaries/photos and visits. 4. Signed ICF by parent/legal guardian; assent as required. Exclusion Criteria: 1. Topical medicated treatments on target area within 2 weeks. 2. Active skin infection or severe eczema flare at target site. 3. Known allergy to product components. 4. Participation in another study within 30 days. 5. Any condition judged by investigator to preclude participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry skin are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry skin

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Luciadas

    Lisbon, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.